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ABSTRACT
The phenoxazine core has been explored in the development of chromophoric systems that
have seen use as fluorescent probes and therapeutic agents in combating illnesses of many forms.
This thesis reports the synthesis and evaluation of some novel phenoxazine and
benzo[a]phenoxazine analogs. Phenoxazinium are charged lipophilic molecules and the recent
resurgence of π-Delocalized Lipophilic Cations (DLC) hypothesis in the combat against protozoan
illnesses has prompted focus on the synthetic exploration of the derivatization of their architectures
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properties found throughout the literature of their development as antimalarials.
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1

INTRODUCTION

As cited in the unofficial excerpts of the modernization of man, many years ago a hunter went
out for a hunt after a lightning storm. The hunt was unsuccessful because most of the vegetation
had been destroyed by the fire from the skies. Frustrated, he began deliberately swinging his amber
glowing spear at a nearby brush. Soon after, the bush erupted in flames and from it emerged birds
with sparked feathers. The birds died shortly after. The hunter attracted by the aroma of freshly
combusted meat, hastily gave it a tasting try and to his pleasant surprise the bird was delicious. He
coined the phenomena Baba Ku, in honor of his father Kuruk. Excited to share his recent discovery
with the rest of his village, he swam back inshore to share the findings with his village chief, who
after hearing the story and tasting the bird, ordered every man in the village to swing their spears
at every bush on the island until the fiery birds ascended. After days of tirelessly beating the heck
out of every bird perched bush, most of the fruitful vegetation in the village was destroyed. All the
villagers were exhausted with no reliable sighting of the bird. With their main source of food gone,
the villagers were angry and starving. Alas for the hunter and his family, they were banished from
the village that night. They found shelter in a cave excavated by the waves on the shorelines, and
once again the hunter made another discovery. He found that striking the rock bearing end of his
hunting spear against the rigid walls of the cave, again out of frustration, created sparks which
were reflected by the nearby waves, illuminating the entire cave and surroundings from where he
was able to foresee an indigenous populace invade the hunger weakened village. In a matter of
months all of the village’s resources including its people, were harnessed and plundered by the
invaders. All of it, except for the hunter and his family, was destroyed.
In an analogous development, the middle age saw most of Europe set sail in treacherous waters
beyond the horizon of the world they knew. Some in the name of monarchs, some in the name of
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God, some in the name of science-but most with dreams of discovering and conquering a new
world. When European ships washed on the new shores, they hastily harnessed and carried back
tales of distant indigenous civilizations and the plunders of their lands- many of which were
unknown to Europe. Part of the plunder included plants known by the natives for their remedial
powers in the treatment of many maladies. The wild untamed flora the native co-existed with
served as their apothecary, providing them with many useful shrubs and trees such as the
Eysenhardtia polystachya (commonly known as kidneywood tree) used by the native Aztec as a
diuretic1. During the early days of European colonies in the New World, many settlers and explorer
succumbed in great numbers to diseases. One particularly, inflicted through a mosquito bite and
later discovered to be the result of parasitic infection, wreaked havoc across Europe and in the
New World. The cinchona tree was a native curative plant used in the treatment of the potent
disease, malaria. The kidney wood and cinchona tree played a revolutionary role in the
development of remedies; however, centuries later, observations made in the experimental
investigation of their curative abilities led to many ground-breaking advances in science. In the
15th century, a Spanish physician and botanist, “Don” Nicolas Monardes noticed a “peculiar blue
color” illuminating from the water infusion of the kidney wood tree.2 This same illuminating
phenomenon was observed by the English scientist Sir John Frederick William when holding a
solution of quinine, the compound isolated from the barks of the cinchona tree used in treating
malaria, in sunlight.3 The illumination was the result of a phenomenon that captivated the attention
of many scientists, particularly an Irish physicist and mathematician, Sir George Gabriel Stokes,
who later extensively studied and described the process behind the phenomenon.4
The following accounts, despite one holding greater truth than the other, share the important
notion of serendipitous discovery associated with illumination. The ability to shed light on things
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has been one of the biggest influencers behind the advancement of humans. From the use of wood
fire by prehistoric people to the incandescent light bulb in recent times, illumination has seen its
paramount use as a method of revealing secrets of the dark. In the story of the hunter and his
family, the accidental discovery of manufactured illumination allowed them to foresee and escape
invading savages. In modern day biology and biomedical sciences, the kind of illumination
described by European scientists in the 15th century has played a vital role in assisting scientists
today detect threats and treat humans from invasions by pathological hosts of many forms.
1.1

Absorbance and Fluorescence of chromophores
The systems responsible for the coloration of objects are known in chemistry as

chromophores. The color of objects is directly related to the ability of chromophores to absorb
light. Simply put, the color seen corresponds to the complement of visible light wavelengths not
absorbed by chromophores. Even more interesting is that the chemical basis of sight, itself relies
on the ability of a chromophore, retinal, to absorb light.5 Other examples of very useful biological
chromophores in living systems include heme, the active site of the oxygen carrying protein
hemoglobin, and melanin, the molecules responsible for the coloration of the skin and absorption
of the sun’s ultraviolet (UV) radiation (Figure 1.1).6-7
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Figure 1.1 Structure of some useful chromophores found in humans

The ability of most organic chromophores to absorb light lies in their conjugation- the
successive occurrence of single and multiple bonds. Inspection at the atomic level of these systems
has enlightened scientist on the quantum phenomena associated with their structure and their
relationship between their color and light. In conjugated systems, valence electron mobility is not
restricted to the respective orbital of their unsaturated π connection. Instead, the electrons are
omnipresent, freely roaming throughout the conjugated system, occupying a connected network
of overlapped electron clouds called a delocalized π- orbital. When this is the case, an energy
difference can be observed in the molecule where the electrons in the highest occupied molecular
orbital or HOMO occupy a lower more energetically favorable positon. Electrons present in this
state can be stimulated by light corresponding to the difference in the energy gaps between the
lowest unoccupied molecular orbital (LUMO) and the HOMO orbital to a higher corresponding
energy level or an excited state. This process is simply referred to as absorption, analogous to the
intake of a photon. In general, the length in the conjugation of a chromophore is directly related to
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the wavelength of the light absorbed i.e. the longer the delocalization of π electron, the lower the
HOMO to LUMO energetically difference, thus the larger the wavelength value of absorption
(λmax) on the electromagnetic spectrum.8
Another feature reserved to conjugated systems, is their ability to spontaneously release the
absorbed light. The phenomena of the absorption and subsequent release of light by molecules
have been extensively studied and explained in literature through the use of the Jablonski diagram
shown in Figure 1.2. Electrons that have been excited from their ground state, can expeditiously
relax through non-radiative decay to the lowest vibrational excited state or their first singlet excited
electronic state (S1). This is known as internal conversion. The continuous relaxation of electrons
back to the initial ground state solely through vibrational states result in the generation of heat.
Photoluminescence occurs when electrons return to their ground states, simultaneously emitting
the absorbed light. There exist differences in the physical manifestations (photoluminescence) of
the emitted energy which is governed by the pathway the electron utilizes to return to its ground
state. A distinction of the pathway is the spin state of the electrons, the parameter of intrinsic
angular momentum, afore relaxation. Electrons with varying spins states utilize different relaxation
pathways. When an electron returns to the ground state from its excited singlet state (S1) through
the spontaneous emission of a photon, fluorescence occurs. A fluorophore or a fluorochrome,
similar to a chromophore, is a molecule that can re-emit light upon light excitation. Seldom, an
electron can enter an alternative forbidden spin state known as a triplet state (T1) through
intersystem crossing. Relaxation of electrons from the triplet state to the ground state happens at a
much slower rate than fluorescence and is known as phosphorescence.9
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Figure 1.2 Jablonski diagram
1.2

Dyes
While a chromophore only directs to the part of the molecule responsible for the absorption

of light, there are other structural features of light absorbing systems that also play roles in assisting
coloration. An entire molecule comprised of a chromophore appended with functional groups
(auxochromes) to enhance its coloring abilities is simply known as a dye. Pigments are larger
molecules of analogous framework typically defined by their insolubility in most mediums. While
there exist many natural dyes, most from animal and plant extracts, the majority of dyes are manmade.
As demands for drugs to combat malaria grew because the virulence of the many parasites
responsible for the illness was increasing, organic chemists ran to their laboratory benches to
attempt to synthesize analogs of the only effective cure for the disease, quinine. While attempting
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to prepare synthetic quinine, Sir William Henry Perkin, a British scientist, discovered that rinsing
the dark gunk of the reaction with alcohol created a beautiful purple mess.10 Mauveine was the
name given to this concoction which consisted of several forms of a tricyclic aromatic nitrogen
cation (Figure 1.3). It was the first account for the synthesis of an organic dye, marking what is
considered today, the cornerstone for the synthetic dye industry and industrial synthetic chemistry
as a whole.

Figure 1.3 Structures of major analogs of Perkin's Mauveine dyes

Organic dyes and their chemistries have since evolved from simple fused aromatic
compounds used mainly as colorant in the food and textile industries, into highly modifiable
scaffolds used in a wide range of industrial applications and cutting edge technologies.11 Many of
the popularly used scaffolds include carbocyanines, BODIPY, rhodamine, coumarin, squarine,
oxazine and azo-based dyes (Figure 1.4). Dyes have found uses as fluorescent probes for biomolecular labeling and imaging technology. Fluorophores can be specially designed to respond to
specific stimuli to study the morphology in living systems.12-15 They can be appended to protein
to understand folding mechanism and structures, or to a ligand to explore binding to a receptor and
to understand the target and mode of action of therapeutic treatments.16-17 They can also be
rationally designed to have structure inherent targeting potential.18-20 Their ability to act as light
transistors has seen their increased use in industrial settings as photosensitizers in solar panels.21-

8
22

Fluorophores themselves can be used as therapeutic agents in many applications such as

photodynamic therapy, nucleic acid intercalations, and as small molecules enzymes
activators/inhibitors.22-25

Figure 1.4 Scaffolds of popular organic dyes

1.3

Phenoxazine and benzo[a]Phenoxazine

1.3.1 Introduction
Oxazine refers to any members of a class of molecules containing all four of earth’s most
biochemically relevant elements-carbon, oxygen, nitrogen, and hydrogen bound together in such
a way that- carbon (C) and nitrogen (N) are in a six membered heterocyclic ring containing three
sp2 hybridized carbons.26 Illustrated in Figure 1.5 are the three main classes of oxazine, named 1,2, 1,3-, 1,4-oxazine in reference to the positioning of the oxygen and nitrogen atom on the ring. The
extension of 1,4-oxazine with two fused phenyl rings on either adjacent faces, hence named
phenoxazine, represents an important system in chemistry known for its stability, planarity, and
lipophilic nature. When phenoxazine is flanked by two nitrogen functionalities, a charged imine
and a neutral amine, the scaffold takes on the suffix “ium”. The two groups act as acceptor and
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donor of π-electron across the conjugated system accounting for desirable photophysical
characteristics of the molecule. Consequently, phenoxazinium analogs have found use in various
fields as fluorescent probes.27 Benzo[a]phenoxazinium are analogs of the phenoxazine family
bearing a fused phenyl at the “a” face of one their adjacent benzene rings. Nile blue is a renowned
cationic dye belonging to the benzo[a]phenoxazine family frequently used as a histological
stain.28-30

Figure 1.5 General nomenclature of oxazine, and analogous derivatives and dyes

1.3.2 Synthesis
The preparation of phenoxazine and benzophenoxazine dyes have not much varied since
the original literature mention of the rugged cyclization of catechol with o-aminophenol, only the
amine have been replaced by much more reactive nitroso group.31 The modernized synthesis of
phenoxazine and benzophenoxazine dyes usually begins with the functionalization of 3-
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aminophenol at the N position. The primary amine at the 3-position is a good nucleophile that can
be functionalized with various substituents through a substitution reaction to acquire primary or
secondary amines. Another popular method to include varied amino substituents onto the phenol
is through the reaction of 3-halophenol with the desired amino functionality using C-N coupling
methods such as the Buchwald-Hartwig Cross Coupling Reaction.32

Figure 1.6 General synthesis of phenoxazine and benzo[a]phenoxazine analogs

The next steps in the formation of the dye calls for the conversion of the aminophenol to
5-amino-2-nitrosophenol followed by its reaction with 3-aminophenol or 1-aminonaphthalene in
acetic acid to yield the phenoxazinium and benzophenoxazinium dye, respectively (Figure 1.6).
Unfortunately, the yields for these reactions remain low due to the thermal sensitivity of the nitroso
specie and the promptness of the reaction to cyclize into many other undesired products in the last
step. Inclusion of varied substituents on either terminal nitrogen has called for the use of ethanol
as solvent and catalytic amounts of some mineral acids such as hydrochloric acid or perchloric acid
as reaction promoters, to replace the use of acetic acid in attempts to improve the efficiency of this
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reaction. This method has afforded simple substituents on the terminal nitrogen at improved yields
compared to the conventional methods, but when more “exotic” groups are desired on the dye,
more robust reaction conditions are required such as the use of elevated reaction temperature using
high boiling solvent, longer reaction times, and expensive/toxic catalysts. These conditions are
unfavorable and can lead to the decomposition of the thermally sensitive nitroso intermediate whilst
also promoting the formation of unwanted side product, resulting in challenging work ups and
purification procedures. These challenges often result in the loss of product yield to an already
yield greedy reaction.
It is also important to note that the electronics and steric nuisance of some complex
aminophenols, such as those containing cyclic or aromatic amines, or N-substituted functionalities
with strong electron donating/ withdrawing capability, do not often allow for their conversion to
the corresponding nitroso form necessary for formation of the dye. To circumvent this issue,
activating the ortho position of the aminophenol using alternative nitrogen containing groups have
been devised by organic chemist.
1.3.2.1 Diaryl azo route
A method using a diarylazo intermediate has been employed to synthesize phenoxazine
and benzophenoxazine analogs33. This protocol has proved successful in incorporating
“privileged” functionalities on both N-terminals. It begins with the diazotization of p-nitroanaline
into an arenediazonium salt. Diazonium species are notorious in organic synthesis for their
reactivity. They can react with nucleophiles such as halides, hydride, cyanide, and hydroxide
among many others, where the benzene can favorably lose the diazene group as nitrogen gas to
yield their corresponding substituted benzenes. They are also known to readily react with
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ortho/para-activated benzenes through a diazonium coupling reaction to form a para azo-coupled
product.
In the case of the synthesis of oxazine dyes, a meta-aminophenol is reacted with a
diazonium salt to form a diarylazo molecule. Reaction of the azo compound with 3-aminophenol
or 1-aminonaphthalene in the presence of perchloric acid yields an oxazine dye (Figure 1.7.).
Advantages of this protocol includes simpler work up and purification methods which translate to
reduction of loss of yield. It is important to note when highlighting the diversity of this protocol
for the synthesis of oxazine dyes, that either aromatic reactant can be converted into the azo form
and reacted with the corresponding aromatic lacking the azo group to form the oxazine dye as
shown in Figure 1.7.
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Figure 1.7 Diaryl azo mediated route

1.3.2.2 Diaryl ether route
Another recently developed route extended from the diarylazo intermediate has led to the
synthesis of even more structurally diversified oxazine analogs than any previously reported
methods with improved yields. In the previously reported azo method, the diaryl azo intermediate
could easily be obtained through the azo coupling. Synthetic challenges arose in the final
condensation step of the azo intermediate with the corresponding non-azo aminophenol. In order
to address the short comings of this protocol, Cornish et al. hypothesized that concerting the
molecules by bridging the two reactants together before forming the azo intermediate could
potentially promote the desired cyclization into the cationic compounds. This was accomplished
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experimentally through the initial paring of 3-aminophenol with aryl iodide in a copper(I)promoted reaction to form a tethered diaryl ether intermediate The reaction of the intermediate
with 4-nitrobenzene diazonium tetrafluoroborate resulted in the formation of the diazo compound,
which upon heating with p-toluenesulfonic acid in ethanol cyclized into the desired dye (Figure
1.8).34

Figure 1.8 Diaryl ether route
1.4

Biological application of oxazine dyes
Phenoxazine and benzophenoxazine analogs have been used in an array of biological

applications. Historically, their desirable stability and photophysical properties have made them
particularly attractive for photonic applications such as fluorescence imaging, fiber optics, and in
phototherapies among many others. Oxazine dyes are also charged, planar, lipophilic molecules.
Such features are key in increasing their interaction with lipophilic macromolecules, thus
increasing their therapeutic potential. Recent work in the field of organic chemistry has led to the
emergence of new and efficient methods for the design and preparation of phenoxazine and
benzophenoxazine analogs. These refined synthetic tools have unlocked the construction of
structurally diverse analogs resulting in a resurgence of their application in cutting edge
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technologies. This section will cover recent advances in literature in the biological application of
oxazine based structural analogs. It will be divided in two parts. The first part will highlight the
applications of phenoxazinium dyes as fluorescent probes in the past 5 years with a short mention
of benzophenoxazinnium dyes as their applications have been thoroughly covered in a review
published by our group.27 The second part will be a compressed review of their application as
small molecule therapeutic agents, focusing on their use as delocalized lipophilic cations.
1.4.1 Fluorescence application
1.4.1.1 Phenoxazine
Small molecule organic fluorescent probes are powerful tools in the elucidation of
biological processes. Suitable probes for biological application must follow certain photophysical
requirements for in vivo optical application such as minimal photoinduced damage to biological
samples, and have significant bathochromic shift for relatively high signal-to-background ratios.
Certain physicochemical properties such as size, lipophilicity, solubility, and ionization state must
also be met in accordance to the Lipinski and Veber rules.35-36 Phenoxazinium and
benzophenoxazinium are a class of oxazine fluorescent compounds that have found use in
fluorescence biological application due to their many desirable properties. Modification to their
architectures to enhance their usage and address drawbacks as fluorescent probes have been
addressed in recent literature.
Certain functional units are employed in medicinal chemistry as structural modulators of
the photophysical properties of a chromophore, while other are suited to address the
physicochemical profile of the molecules. In the design of a fluorescent probe with enhanced
properties for biological application, Hell et al. addressed the two in synergy using a common
structural motif. Analogs of ATTO655, an oxazine probe used in single-molecule localization
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microscopy, were synthesized featuring a primary phosphate group 6 to enhance both its
fluorescence quantum yields and solubility for the improved imaging of immunolabeled
cytoskeletal protein vimentin in mammalian cells (Figure 1.9).37

Figure 1.9 Synthesis of phosphorylated ATT655 analog

Some probes are designed to feature a mechanism of florescence ignition as a response to
a stimulus. When the mode of ignition is light induced, it is called photoactivation.
Photoactivatable fluorophores (PAFs) are important in fluorescence application. In in vivo cell
imaging, the photoactivation of a fluorophore can permit for real time monitoring of dynamic
cellular processes.38 Cornish et al.

adapted the phenoxazine scaffolds in designing a

photoactivable probe PA-Oxazine for live cell imaging.39 In their work, they incorporated an azido
group at receptor amine position and an acyl moiety onto the central nitrogen ring that could be
cleaved by UV- light, leaving behind the florescent compound 10, shown in Figure 1.10. The probe
was used in the protein specific labeling of living mammalian cells through linkage to the protein
specific trimethoprim (TMP) tag.
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Figure 1.10 Synthesis of azido-acyl caged photoactivable oxazine analogs

Phenoxazinium probes can also be designed to respond to changes in pH levels. Ge et al.
developed a series of pH sensitive phenoxazinium analogs by appending substituents to their donor
amines that could serve as protonation sites in developing lysosome targetable probes40-41 (Figure
1.11). Their receptor amines were readily protonated/deprotonated or appended with pH sensitive
moieties that could undergo protonation upon change in pH level, which elicited a change in the
emission profile of the dyes.

Figure 1.11 Protonation/deprotonation mechanism of phenoxazinium pH based probes.
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Pickup et al. used click chemistry to append 651-Blue Oxazine dye to glucose/galactosebinding protein (GBP) to develop a probe 11 for the fluorescence sensing of glucose (Figure
1.12).42 Phenoxazinium dyes are solvatochromic systems that have been shown to experience
bathochromic shift in polar environments.43 Upon binding of the GBP-Blue Oxazine 11 to the
protein, there is conformational change which increase the polarity in the binding site of the
enzyme resulting in a noticeable increase in fluorescence intensity of the fluorophore.

Figure 1.12 Copper mediated click reaction of Blue Oxazine azide to GBP-alkyne to
synthesize a GBP-Blue Oxazine glucose sensing probe.
Another common application of phenoxazinium based fluorescence is in developing probes
for metal sensing. Metal sensors can be obtained by appending known chelating ligand onto the
amine of the phenoxazine. Lu et al. investigated the use of di(2-picolyl)amino moiety as a metal
binding domain on the oxazine scaffold to develop suitable probes for the intracellular sensing of
divalent metal ions. Appending di(2-picolyl)amino directly onto one of the terminal nitrogen
showed the selectivity of probe 12 towards copper(II) ions.44 In another study, they demonstrated
the versatility of the oxazine scaffold in metal sensing chemistry. Increasing the length of the
connecting chain of the binding domain to the fluorophore by two carbons resulted in a probe 13
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more selective towards the sensing of the larger zinc(II) ion perhaps due to the increase range of
motion of the binding ligand (Figure 1.13).45

Figure 1.13 Di(2-picolyl)amino based phenoxazinium probes for divalent metal sensing.

Photoinduced electron transfer (PET) quenching is a popular mode of fluorescence turn on
where a donor molecule’s ability to transfer an excited state electron to a neighboring receptor
chromophore is hindered, resulting in the increase in fluorescence intensity of the acceptor
fluorophore.46 Kobertz et al. developed a NIR probe 14 constituting of the known triazacryptand
(TAC) binding moiety (donor) covalently linked to an oxazine fluorophore (receptor) for detecting
changes in intracellular and extracellular potassium ion (K+) concentrations using a PET
quenching sensing mechanism.47 Figure 1.14 depicts the mechanism of fluorescence quenching;
when the metal is lodged in the binding domain of the probe PET to the chromophore is quenched,
resulting in enhanced fluorescence emission of the fluorophore.
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Figure 1.14 PET quenching mechanism of NIR potassium sensing

Dyes can be built into nanoparticles to enhance their use as fluorophores. Nanoparticles
can act as surfaces for the adhesion of small molecules chromophores in the design of fluorescent
probes for in vivo use. The nanoparticle must be judiciously selected to have specific features that
allows for their appendage without sacrificing the optical performance of the fluorophore, while
improving physicochemical properties of the probe such as specific cellular uptake, solubility, and
overall pharmacokinetics.48 Dextran-coated iron oxide nanoparticles are excellent non-toxic and
biodegradable supports that have found uses in the preparation of multifunctional probes.49
Hilderbrand et al. covalently linked Oxazine 1 to a dextran-coated iron oxide nanoparticle via a
5-xopentanoate linking unit to create a probe 15 for the in vivo sensing of reactive oxygen/nitrogen
species (ROS/RNS). 50 As shown in Figure 1.15, in the presence of ROS/RNS the nanoparticle to
dye linking unit is oxidatively cleaved releasing the free fluorescent compound Oxazine 1.
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Figure 1.15 ROS/RNS oxazine based nanoprobe sensing mechanism.

Fluorescence imaging has been used in the medical field as a noninvasive method to
visualize tissues in the body. Near infrared (NIR) fluorophores are of particular advantage than
visible light probes because they allow for visualization without competing with absorption and
autofluorescence from other macromolecules and water in the visible light spectrum. Our lab has
adapted Oxazine 4 as a NIR fluorophore in the tissue specific illumination of the brachial plexus
and sciatic nerve (Figure 1.16).51 To our knowledge, this work represents the first example of a
small molecule nerve specific NIR fluorophore.
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Figure 1.16 In vivo fluorescence imaging of brachial plexus (BP, top rows) and sciatic nerve
(SN, bottom row) in the rat with Oxazine 4 by Park et al. (reprinted from reference #51)

Gremlich et al. developed the NIR oxazine fluorophore AOI987 capable of penetrating the
blood brain barrier and bind to amyloid plaques for their in vivo detection.52 The buildup of
amyloid plaque in the brain has been associated with Alzheimer’s pathogenesis (Figure 1.17).53
The non-invasive detection and monitoring off the plaques can offer an avenue to further study its
association to the disease to improve treatment methods.
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Figure 1.17 In vivo fluorescence imaging of amyloid plaques with AOI987 in mice model by
Gremlich et. al (reprinted from reference #52)

1.4.1.2 Benzophenoxazine
Analogous to phenoxazinium, benzo[a]phenoxazinium dyes have seen their shared
popularity as biological sensors. Appending groups at their donor/acceptor sites that can be
protonated/deprotonated at different pH levels, resulting in fluorescence change, has served as a
good detection method to track intercellular pH changes. Ihara et al. reported the incorporation of
N-substituted pyridinyl groups on the receptor of Nile blue to design a water soluble probe 16 for
intercellular pH sensing (Figure 1.18).54 Similar probes were designed by Zhan et al. by attaching
various electron donating phenyl moieties to the scaffold to yield a pH activable lysosome probe.55
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Figure 1.18 Reversible Near-Infrared pH Probes based on benzo[a]phenoxazinium

A pH-responsive N-(-ethylated)pyridiniumylbenzo[a]phenoxazine dye BPox was utilized
by Chen et al. in the design of an albumin-based nanoprobe for the ratiometric photoacoustic
imaging of tumors.56 Photoacoustic spectroscopy, the measurement of the sound waves generated
during the thermal relaxation of an excited probe, can be used in compliment to fluorescence for
enhanced biological imaging.57 The benzophenoxazine dye along with another pH unresponsive
NIR dye IR825, used in this experiment as an internal reference, were encapsulated into human
serum albumin (HSA) to form a nanoparticle HSA-BPox-IR825 that could penetrate the
hydrophobic barriers of biological tissues for an accurate pH responsive imaging of tumors (Figure
1.19).
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Figure 1.19 Illustration of HSA–BPOx–IR825 nanoprobe.

A near infrared benzophenoxazinium based probe 17 was specially engineered to contain
an o-phenylenediamine group that could undergo intramolecular cyclization in the presence of
sodium nitrite to form compound 18. Structural change of the reactive o-phenylenediamine group
of the probe into a triazole ring in the presence of nitrite species ring elicited PET quenching,
leading to fluorescence increase of the probe used for the selective in cellular imaging of
exogenous nitrite (Figure 1.20).58
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Figure 1.20 Detection mechanism of exogenous nitrite.

Fluorescent dyes can be incorporated onto surfaces of material such as glass or optical fiber
to create surface sensor for an array of applications. The fluorophore Oxazine 170 perchlorate was
coated onto ethyl cellulose to produce a thin membrane used in the detection of ammonia in
different envirnoments.58-59

Figure 1.21 Structure of commercially available Oxazine 170

Some oxazine analogs have also been evaluated in the structure inherent targeting of
specific tissues. Our group has recently assessed and shown the ability of some oxazine analogs to
specifically target tissues to be used as contrast agent in NIR image guided surgery. We
demonstrated the superior tissue uptake of Oxazine 170 to several other analogs and proved it to
be a successful fluorophore in highlighting thymus tissues in mice and pig models.60

27

Figure 1.22 Color image, NIR fluorescence, and a merged
image of the two of thymus tissue in mice stained using Oxazine 170 contrast agent, by
Wada et al. (reprinted from ref. 60)

1.4.2 Therapeutic application
1.4.2.1 Photosensitizer
Photodynamic therapy (PDT) has garnered attention in medicine as a versatile treatment
method for various medical conditions such as bacterial, fungal, viral infections, and in the fight
against cancer. In PDT, a photosensitizer (PS) localized at the site of treatment is exposed to light
to undergo series of electronic transitions which elicit toxicity in the micro environment through
the generation of reactive oxygen species, resulting in death of the targeted cell as illustrated in
Figure 1.23.61 An important feature of PDT is the ability of the photosensitizer to effectively
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associate with the malignant target, to avoid the obliteration of healthy sites during light treatment.
Some oxazine dyes have been known to selectively distinguish malignant from healthy tissue in
animals and have been investigated for their photosensitizing efficacy in the treatment against
cancer.62-63 Oxazine dyes have also been explored as photosensitizer in the Antimicrobial
Photodynamic Therapy (APDT) of localized infections.64-65 Another photosensitizing application
of oxazine involves their use in the treatment of skin-tropic strains of Leishmania.66

Figure 1.23 Illustration of the generation of ROS in photodynamic therapy (PDT).

1.4.2.2 Antimalarial
A thorough review of literature reveals that prior to 2005, very few examples existed of the
development of oxazine dyes as small molecule therapeutic agents. The few cases were isolated
assessments of commercially available analogs, typically without further synthetic development
to expand the analog set. As a result, for years the pharmacological potential of oxazine dyes
remained vastly unexplored. Very recently, some oxazine dyes functionalized with alkyl,
heterocyclic, and aromatic substituents were evaluated as anti-malarial agents. Their use as
antimalarial laid on the delocalized lipophilic cation (DLC) hypothesis in which hydrophobic
cations containing delocalized π-electrons traverse the cellular membrane into the cytosol and
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accumulate inside organelles under a negative transmembrane potential such as the mitochondria,
and digestive vacuoles to inhibit metabolic activity of the parasite. Their resurgence in the fight
against malaria has prompted focus in the synthetic exploration of their architectures, to which
several lead molecules with promising activities against chloroquine resistant plasmodium strains
have been developed (Figure 1.24).67-71

Figure 1.24 Illustration of the accumulation of DLC inside the mitochondria under negative
membrane potential.

Figure 1.25 Oxazine dyes explored as antimalarial.
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2

SYNTHESIS AND PHOTOPHYSICAL PROPERTIES OF PHENOXAZINE
ANALOGS DESIGNED AS POTENTIAL ANTIMALARIALS

2.1

Introduction
Malaria remains amongst the deadliest infectious diseases plaguing developing countries with

tropical climates.72 Although tremendous strides have been made in the treatment of malaria, the
resurgence of drug resistant parasitic strains has refocused scientific efforts to enhance the potency
of known therapeutics and the druggability of existing targets. It is often these can occur in a
synergistic manner, and medicinal chemists have employed delocalized lipophilic cations (DLCs)
with intrinsic fluorescence and organelle targeting properties as an emerging strategy in the fight
against malaria.
Oxazines have garnered interest from scientists in both academia and in the industry as a useful
developmental scaffold. When sandwiched between two phenyl rings, a rigid tricyclic system can
be created that tend to be characterized by strong chemical stability and increased lipophilicity.
Such system has seen its use in the building or as active substituents in molecules exhibiting many
interesting biological properties.73-76 Phenoxaziniums are cationic analogs of 1,4-oxazine with two
adjacently fused benzenes containing an amine and iminium moiety para to the central nitrogen
(Figure 2.1). A survey of literature reveals that many phenoxazinium analogs exhibit desirable
photophysical properties such as strong absorption of visible light and high fluorescence quantum
yield which have fixated their use as fluorescent probes for an array of applications. The utility of
the phenoxazinium scaffold is not only limited to its photo applications. It has also seen its use in
developing small molecules therapeutic agents in the treatment against various infections.
Phenoxaziniums have been explored in the development of small molecule ligands in the treatment
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of chloroquine resistant malaria; however, such cases have mostly featured the assessment of
commercially available analogs, typically without further synthetic development for structureactivity relationship (SAR) studies. This is perhaps because of synthetic challenges encountered
during their analog derivatization.

Figure 2.1 Scaffold of oxazine, phenoxazine, and phenoxazinium dye.

Previously, our group has described the effect of appending alkyl substituents on the amines
of the phenoxazinium scaffold on its optical performance and biological uptake. This approach
gave insight of the effect of lipophilicity on the optical profile and binding abilities of this class of
compound, and the remarkable ability of several dyes with short alkyl chains to specifically target
and bind to nerve, pancreas, and thymus tissues (Figure 2.2).51, 60 Very recently some phenoxazine
and benzophenoxazine analogs functionalized with alkyl, heterocyclic, and aromatic substituents
were evaluated for their anti-malarial properties to which several molecules with short chain,
cyclic, and aryl amine moieties were shown to have promising activities against chloroquine
resistant plasmodium strains.68-71

Figure 2.2 Prototype phenoxazine probes for thymus, nerve, and pancreatic imaging.
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Many of the analogs assessed as antimalarial bear skeletal resemblance to those used in our
studies. Account for both designs, we sought to mimic trends found in the design of analogs with
good antimalarial activities in literature with those found in the preparation of analogs with
enhanced biological uptake properties to design and construct systems with good intrinsic
fluorescence and improved antimalarial potency. In this work, phenoxazinium and
benzophenoxazinium dyes containing short chain, rigid and cyclic amines were synthesized as an
effort to enhance their use in the treatment of malaria. Phenoxazinium analogs containing
rigid/cyclic moieties incorporated into the extremities of their chromophoric systems represent an
exotic analog set that unfortunately, to date, only a handful have been reported in the literature. In
this context, this work also introduces an efficient path for the diversification of the phenoxazinium
scaffold.

2.2

Project Rationale

Figure 2.3 General modifications to the phenoxazinium scaffold

The efficacy of small molecule therapeutic methods where an intracellular receptor is (believed
to be) targeted often lies in the ability of the ligand to traverse the cell’s first barrier of protection,
the plasma membrane. The plasma membrane consists of a hydrophobic phospholipid bilayer and
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proteins that allow for the selective diffusion of substances in and out of the cell. Medicinal
chemists have described predictive factors that can influence favorable diffusion of small
molecules across the plasma membrane in the Lipinski’s “Rule of 5” such as polarity, size, and
lipophilicity.77 Phenoxazinium are lipophilic compounds that can traverse the plasma membrane
due to their distributed hydrophobic surface area as a result of the delocalization of pi electrons
across the conjugated molecule. Once in the cytosol, they can specifically accumulate within
organelles under negative potential because of their cationic nature.
The mechanism of action and factor governing the efficacies of phenoxazine in the treatment
against malaria remains unclear, as it is the case with most potent antimalarials; however, the
efficacy of the treatment methods have been recently correlated to the ability of the compounds to
accumulate inside the membranes of organelles under a negative potential such as the
mitochondria, digestive vacuoles, and inside the plasmodium specific organelle, the apicoplast,
which can disrupt cellular activities in the parasitic cells, leading to their death.78-79 In order to
enhance the efficacy of this treatment, we have synthesized a focused library of systematically
modified substituted phenoxazinium analogs taking into account plasma membrane penetration
and related antimalarial “drug like” design to begin speculating factors modulating their
antimalarial potency.
We have synthesized compact analogs with short chained alkyl functionalities at multiple
positions on the scaffold in the hope to enhance the cellular uptake functions and discourage
promiscuous interaction with macromolecules during cellular distribution while working to
maintaining their antimalarial potency (Figure 2.4). We have also prepared analogs with a fused
phenyl to increase the delocalization and the hydrophobic surface area. Several analogs containing
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the fused phenyl were equipped with a hydroxy group to increase water solubility and to serve as
a handle for potential bioconjugation.

Figure 2.4 Flexible, bridged, and cyclic phenoxazine and benzo[a]phenoxazine library

2.3

Experimental Overview

2.3.1 General
All starting reagents used were obtained commercially from major chemical suppliers and
were not purified before use. All 1H NMR and 13C NMR data were obtained on a Bruker Avance
400 spectrometer. HRMS data were obtained on a Waters Micromass Q-TOF mass spectrometer
coupled with a Waters 2695 HPLC. DMSO was obtained from Acros Organics (99.9%) (Belgium)
and methanol was obtained from Sigma-Aldrich (≥ 99.9%) (St. Louis, MO). Absorbance spectra
were acquired using a Cary 3G UV-visible spectrophotometer (Varian Inc., Palo Alto, CA)
interfaced to a PC. Fluorescence spectra were achieved using a Shimadzu RF-5301
Spectrofluorometer (Shimadzu Europe Inc.) interfaced to a PC. Excitation was achieved using a
Xenon Arc lamp, model PS 300-1, (ILC Technology Inc., Sunnyvale, CA). Spectroscopic studies
were performed in disposable plastic cuvettes and with a path length of 1 cm.
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2.3.2 Preparation of N-alkylated-3-aminophenol

Figure 2.5 Synthesis of N-alkylated 3-aminophenols

All the straight chain alkylated compounds 27a-b were prepared by dissolving 3aminophenol in DMF, adding K2CO3, and rapidly heating the reaction flask to 70 °C. The alkyl
halides were all liquids and were added dropwise for 15-30 min. Reactions were monitored by
TLC until completion. Reaction workup proceeded by first removing DMF through serial
extraction with ethyl acetate and water. The combined organic fractions were concentrated under
reduced pressure and purified using column chromatography on normal phase silica and eluting
with various compositions of Hexanes/AcOEt.
For the synthesis of compounds 28a-d, 3-aminophenol or m-anisidine (1.0 mol) was
dissolved in dried toluene. Triethyl amine (2.3 mol) and Na2CO3 (2.5 mol) were added to the
solution, followed by the addition of the 1,4-dibromobutane 28a-b or 1,5-dibromo pentane 28c-d
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(1.3 mol) dropwise over a period of 45-60 min. The reaction flask was heated at 110 °C under
nitrogen o.n. Reactions were monitored by TLC until completion. Reaction workup proceeded by
decanting the reaction liquid and extracting with water/DCM to remove the salts. The combined
organic layers were concentrated under reduced pressure and purified using column
chromatography on normal phase silica and eluting with various compositions of AcOEt/Hexanes.
Cyclic aminophenol 29 was prepared by reacting 3-aminophenol (1.0 mol) with 1,4dibromobutan-2-ol (1.2 mol), and potassium carbonate (1.1 mol) in distilled water in a crimpsealed thick-walled glass tube equipped with a micro-magnetic stirrer. The reaction tube was
placed in a CEM Microwave Synthesis System, operated at 120 °C for 45 min with a power 150
Watt. After completion of the reaction, the organic portion was extracted into ethyl acetate.
Removal of the solvent under reduced pressure and flash column chromatography using with
various compositions of AcOEt/Hexanes as eluent afforded the pure product as an off-white solid.
Compound 30 was prepared by heating 3-aminophenol (1 mol) and bis(2chloroethyl)amine (1.2 mol) in sulfolane at 150 °C o.n. Reaction progression was monitored by
TLC until completion. Reaction workup proceeded by the dilution of the reaction in cold acetone.
The reaction was allowed to stir in cold bath for an additional hour, to form a precipitate. The
collected crystals were washed with acetone, dried, and recrystallized from methanol to yield the
pure product as off-white solids.
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2.3.3 Synthesis of nitrosylated intermediates

Figure 2.6 Nitrosation of N-alkylated 3-aminophenols (compounds were used without
purification)

All nitrosation reactions were conducted in the same manner as shown in Figure 2.6. An
alkylated aminophenol (1.0 mol) was dissolved in EtOH and a molar excess of HCl was added.
The entire system was cooled on a cold bath. Sodium nitrite (1.2 mol. eq.) was dissolved in the
minimal amount of DI water and very carefully added dropwise to the reaction flask over 30-45
min. The reaction was allowed to stir for an additional 2-3 h on the ice bath. The precipitate was
washed with water, ultra-sonicated in Et2O, and filtrated to remove inorganic salts to give nitroso
compounds 31-34, which were used in the next step without further purification.
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2.3.4 Synthesis flexible and cyclic benzo[a]phenoxazinium dyes.

Figure 2.7 Synthesis of benzophenoxazine derivatives.

The benzo[a]phenoxazinium derivatives were prepared by refluxing the nitroso precursors
(1.0 mol) with 1-naphthalamine (1.0 mol) for dyes 20, 21, 22a or with 5-Amino-2-naphthol (1.0
mol) for dyes 19a-b, 21, and 22a in IPA with hydrochloric or perchloric acid as shown in Figure
2.7 using a Dean Starks apparatus. Dye formation was visible with color change to dark blue
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occurring within the first hour of heating. The reaction was monitored by UV-Vis and halted when
there was no change in its absorption spectra at ~600nm. The cooled reaction mixtures were
concentrated under reduced pressure. The dark residue was then dissolved and ultra-sonicated in
ethanol, precipitated with diethyl ether, and purified using flash column chromatography using
various compositions of AcOEt/Hexanes or MeOH/DCM as eluent to afford the pure product as
dark blue solids.
2.3.5 Preparation of diazonium salt (Diazotization)
Diazotization starts with a three-step conversion of acetanilide to p-nitroaniline,
Acetanilide was added to a 50% solution of nitric acid and sulfuric acid on an ice bath with stirring
for 30 min and allowed to reach room temperature. The reaction was quenched over ice and
allowed to stir for an additional 20 min. The precipitate was collected, washed with water, and
recrystallized from EtOH to yield pure p-nitroacetanilide as creamed colored solids. To an aqueous
solution of p-nitroacetanilide under stirring, concentrated HCl was added dropwise for 30 min and
heated under reflux. The reaction was cooled to r.t, quenched over ice water, and basified to pH
5.0. The precipitate was collected, washed with water, and dried in vacuo to yield pure yellow pnitroaniline. p-Nitroaniline (1.0 ml) dissolved in a solution of concentrated hydrochloric acid and
water was cooled in an ice-bath and sodium nitrite (1.0 mmol) dissolved in water was added
dropwise. The reaction mixture was stirred at 0-5°C for an additional 20 min which turned to an
orange color, signaling the formation of the diazonium specie that was used in situ in the azo
coupling reaction without further purification by adding a methanolic solution of 8aminoquinoline, or 1-naphthalamine to the mixture at room temperature. The precipitate was
filtered, washed with cold ethanol, and recrystallized from 2-propanol to yield the diarylazo
intermediate 35.
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Figure 2.8 Synthesis of the diazonium salt
.
2.3.6 Azo coupling and synthesis of bridged benzophenoxazinium analogs

Figure 2.9 Modified synthesis of bridged benzophenoxazinium dyes 23 and 24.

Equimolar amount of diarylazo aromatic intermediate 37 and bridged aminophenol were
dissolved in dried ethanol, and heated overnight at 75 °C. Reaction progression was monitored by
TLC until completion. The reaction mixture was concentrated under reduced pressure, and purified
by ultra-sonication in ethanol and diethyl ether, and purified using flash column chromatography
using various compositions of AcOEt/Hexanes or MeOH/DCM as eluent to afford the pure product
23 and 24 as dark blue solids. The structure of dyes and the intermediates were confirmed by 1H
NMR, 13C NMR (Appendix).
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2.3.7 Spectroscopic studies of dyes
2.3.7.1 Determination of molar absorptivity
Serial dilutions of each dye were prepared in ethanol with concentrations ranging from
0.2×10-5-1.60×10-5 M. The maximum wavelength of absorption (λabs) of each dye was determined.
The molar absorptivity values of each dye were determined using Beer’s law. Duplicate
absorbance measurements were obtained, and the aver-age molar attenuation values were reported.
2.4

Results and Discussion

2.4.1 Synthesis of compact and bridged analogs
The synthesis of phenoxazine 25f and benzo[a]phenoxazine 19-22 were achieved through the
condensation reaction of a nitrosylated 3-(alkylatedamino)phenol with the corresponding 3(alkylatedamino)phenol lacking the nitroso group, naphthalamines, or with 5-aminonaphthalen-2ol, respectively. The synthesis begins with preparing alkylated aminophenols. The general method
to obtain alkylated aryl amines is through the direct alkylation of aryl amines with alkyl halides.
The alkylation reaction for analogs containing straight chain alkyl groups were conducted using
equimolar amount of commercially available iodomethane or iodobutane and 3-aminophenol and
doubled the molar amount of potassium carbonate in DMF at 70 °C.
Dialkylation of 3-aminophenol presented a challenge as primary amines are good nucleophile
that when reacted with short chain alkyl halide form a secondary amine, which becomes an even
better nucleophile than its predecessor. The secondary amine can react with excess alkyl halide to
form a tertiary amine, which is also more nucleophilic than the previous two species, continuing
the alkylation train until the subsequent formation of the fully alkylated quaternary
amine/ammonium salt. This could be observed experimentally on the TLCs of the reaction
progression showing the consumption of the starting reagents and the emergence of multiple
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product spots corresponding to the secondary, tertiary and their salts, as well as the quaternary
ammonium salt.

Figure 2.10 Arbitrary scale of basicity and nucleophilicity of substituted aryl amines.

Iodide has been widely used to enhance the reactivity of amines with certain electrophiles in
SN2 nucleophilic substitution reactions. Alkyl iodides often tend to decompose during storage
when expose to light, or in sealed reaction tube at elevated temperatures, which can contribute to
the decrease of the efficacy of the dialkylation reaction. To promote the formation of the product
based on the molar ratio of the alkylating agent and aryl amine, catalytic amount of potassium
iodide was added to the reaction mixture. The addition of potassium iodide favored the formation
of the desired substituted amines perhaps by activating and enhancing the reactivity of the
iodoalkane, or by stabilizing the salts of the major product to make the reaction remarkably faster
and more effective. The reaction work up consisted of several washes with cold water to remove
base and some of the quaternary salts from undesired alkylation, followed by a series of extractions
from cold water and AcOEt to remove DMF. The oily residues were then taken up in ethanol,
filtered to remove salts, and then loaded onto silica for purification using normal phase silica and
ethyl acetate/hexanes solvent systems.
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The cyclic aminophenol 28 were prepared following published procedures involving the
reaction of 3-aminophenol with vicinal dibromoalkane of varying length, depending on the size of
the cyclic moiety desired, in the presence of TEA in toluene under nitrogen gas. After TLC showed
full consumption of the starting reagents, workup of the solvent involved the decanting of the
liquid from the reaction mixture, which was filtered to remove any solids, and extracted with
water/DCM. The combined organic layers were concentrated under reduced pressure and purified
using column chromatography on normal phase silica and eluting with various compositions of
AcOEt/Hexanes. Following similar protocol for the synthesis of compound 29 showed little
reaction progression after 2 hr when monitored using TLC and a smorgasbord of products on TLC
when allowed to react overnight under inert atmosphere. For this reaction, microwave conditions
were adopted and proved to be superior to the conventional methods in attaining satisfactory
yields. Water was used as both solvent and reaction promoter without the need for base. The
product was isolated through extraction with ethyl acetate and purified using column
chromatography on normal phase silica and eluting with various compositions of AcOEt/Hexanes.
The next step in the formation of the final product consisted of the nitrosation reaction of
the alkylated aminophenols following published procedures. Concentrated HCl was added to an
ethanolic solution of the starting material placed in an iced bath. Sodium nitrite (1.2 mol. eq.)
dissolved in minimal amount of water was added slowly over 30-45 min. The reaction was
maintained at cold temperature and allowed to stir for 3 hours. If no precipitate formed, the reaction
was placed in a fridge overnight. The precipitate was collected, washed with water, ultra-sonicated
in Et2O, and filtrated to remove inorganic salts to give the nitroso compounds. Special care was
taken to maintain the compound at cold temperature, as heating above room temperature leads to
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the decomposition of the compound. The nitroso compounds were used without further
purification.
Dye formation was achieved through the condensation reaction of equimolar amount of the
nitroso precursors (1.0 mol) with aminophenol, or 1-naphthalamine, or with 5-Amino-2-naphthol
for the formation of phenoxazine, or benzophenoxazine and their phenol analogs, respectively.
The reaction was conducted in IPA with hydrochloric or perchloric acid as shown. A Dean Starks
apparatus was used to remove water formed during the reaction to drive forward the cyclization
into the dye. Dye formation was visible with a color change of the solution to dark blue occurring
within the first hour of heating. The reaction was monitored by UV-Vis and halted when there was
no further change to the ratio of the peaks observed on the absorption spectra. The cooled reaction
mixture was concentrated under reduced pressure. The dark residue was then dissolved and ultrasonicated in ethanol, precipitated with diethyl ether, and purified using flash column
chromatography with various compositions of AcOEt/Hexanes or MeOH/DCM as eluent, to afford
the pure product as dark blue solids.
Fused analogs were synthesized following a slightly altered arylazo mediated route.
Bridged aminophenols do not readily convert into the desired nitroso intermediates for subsequent
cyclization despite the presence of a hydroxy ortho/para directing group, therefore this route could
not be explored for the synthesis of the desired fused benzo[a]phenoxazine analogs. Literature
reports one example of the synthesis of analogs of this bridged class. It employs an arylazo
mediated route instead of the common nitroso intermediate. Alternatively, compounds 23, and 24
were prepared following the azo method which start by the preparation of p-nitroaniline which is
then converted into the diazonium salt through the nitrosation of the amine with nitrous acid
(generated in situ from sodium nitrite and sulfuric acid). Diazonium salt are unstable product that
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were used in the next step without further purification. The diazonium salt was reacted in situ with
the aminophenol to form an electronically activated aminophenol. Heating of the diarylazo with
the corresponding bridged aminophenol in DMF in the presence of percholric acid lead to the
formation of the dyes, shown by appearance of a new peak at ~640 nm on the UV-vis spectrum,
characteristic of phenoxazinium dyes. The following method was found to be well suited to
introduce bridged amino moieties into the benzophenoxazine architecture but the yields were
exceptionally low, judged from the intensities of the dye to starting material peak on UV-Vis (7%).
Reaction conditions were tweaked replacing DMF with dry ethanol as solvent, and heating the
mixture under reflux condition for 1 hr under inert atmosphere, after which the reaction was
allowed to stir at r.t for another 5 hr. The reaction mixture was concentrated under reduced
pressure, and purified by ultra-sonication in ethanol and diethyl ether, and purified using column
chromatography on normal phase silica and eluting with various compositions of AcOEt/Hexanes
and DCM/MeOH.
2.4.2 Characterization
Compound 22b was chosen as a representative for complete chemical characterization
and analysis. 1H NMR spectra measured in DMSO-d6 is shown in Figure 4 with color coded
boxes matching the peaks to protons on the structure. The protons on the carbon of the
piperazine ring appear as doublets in the aliphatic region (3.64-3.26 ppm) with an integration of
four each. The rest of the signals appear in the aromatic region of the spectrum. Most evident
being the OH- proton appearing as a singlet at 11.2 ppm, followed by the iminium protons
appearing as a doublet at 10.37-10.25 ppm, this shift due to the due to the conjugation of the
molecule. Amine and HCl protons of piperazine are both shifted downfield because of the
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presence of the HCl. The rest of the peaks appear in the range of 6.8-8.4 with their respective
splitting and integrations. Solvent and water peaks are visible at 2.5 ppm and 3.2 ppm.

Figure 2.11 Figure 2.11 1H NMR spectrum of compound 22b
13

C NMR spectrum of compound 22b displays 16 peaks from 97.3-162.9 ppm

corresponding to the 16 aromatic carbons and two peaks at 46.2 ppm and 42.7 ppm
corresponding to the four carbons on the piperazine ring, appearing as two equivalent carbons.
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Figure 2.12 C NMR spectrum of compound 22b

2.4.3 Photophysical and physicochemical properties of analogs
In order to determine the effect of the N-alkylation of the dyes on their optical profiles, the
optical properties of all dyes were conducted in EtOH and compared to commercially available
Nile blue. The addition of a hydroxy group on the phenyl group increased solubility, increasing
the molar absorptivity of the compound by ~20,000 L·mol−1·cm-1 for dyes 19a-b. Addition of
cyclic alkyl group did not significantly affect the absorbance, but the stoke shift for the compounds
were lowered by a half and by a quarter respectively for dyes 20 and 21 compared to NB. The two
bridged compounds 23 and 24 had blue shift absorption λmax values from 5-30 nm. Compound 22b
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had the lowest absorbance value and highest stokes shift of all compounds in this series and
featured the most water-soluble groups.
Dyes

λabs

λem

Stokes Shift (nm)

ε (L·mol−1·cm-1)

NB

630

660

30

76,800

19a

615

654

39

87,520

19b

620

660

40

99,430

20

620

668

48

44,000

21

635

666

31

22,110

22a

630

665

35

31,640

22b

600

659

59

42,140

23

635

646

11

31,660

24

660

673

13

48,830

25f

645

658

13

17,000

Table 2.1 Optical properties of dyes 19-25f

Figure 2.13 Absorbance spectra of compounds 19-25f.
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Figure 2.14 Fluorescence spectra of dyes 19-25f

The physicochemical profile of small molecules is very important in their design as
potentially bioactive ligands, especially in a ligand-based design where definitive information on
a binding target or receptor is not available but a scaffold of interest is known. Physicochemical
assessment allows for the understanding of the molecular character of analogs of a scaffold such
as their molecular weight; Log D; numbers of H-bond donors (HBD) and H-bond acceptors
(HBA), which are determinants of the interaction of the ligands with macromolecules once inside
the body and heavily influence their solubility and permeability. In medicinal chemistry, those
factors are descriptors of the molecules’ bioavailability which is used as a primary descriptor to
assess the “drug-likeness” of a scaffold- how those properties measure with those of approved
drugs. Physicochemical calculation can be performed using modern software that are convenient
to use. We evaluated the physicochemical profile of the synthesized phenoxazine derivatives using
Chemaxon calculator plugin in Marvin using the Lipinski and Veber rules as the first net for fishing
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analogs with undesirable profiles from our selection pool and comparing them to previously
synthesized antimalarial SSJ206 and MB. For the investigation of a hypothesized mode of action
for this scaffold, we have also calculated the molecular surface area (MSA), and dipole moment
(DM).

Compound M.W

LogD

NH/OH HBD/A MSA

DM

MB

284.40

-0.62

0/0

0/4

388.00 10.85

SSJ206

336.45

-0.89

0/0

0/4

508.93 9.00

19a

405.79

-0.16

1/1

1/3

387.86 10.83

19b

433.85

0.60

1/1

1/3

449.11 11.61

20

351.83

0.29

1/0

1/3

422.09 11.77

21

367.83

1.32

1/0

2/3

433.23 12.77

22a

429.86

0.73

1/0

1/3

450.05 11.93

22b

467.3

-2.12

1/1

2/3

443.03 12.51

23

401.80

-0.28

1/0

2/2

387.43 11.35

24

441.11

0.81

1/0

1/3

387.17 11.37

25a

381.81

-0.70

2/0

0/3

414.32 10.66

25b

353.76

-0.60

2/0

1/3

350.07 11.56

25c

367.79

-0.16

2/0

1/3

382.75 11.18

25d

367.79

-1.33

1/0

1/3

381.65 8.74

25e

409.87

1.28

1/0

1/3

475.99 11.86

25f

354.83

-1.42

0/1

1/3

427.46 4.75

Table 2.2 Physicochemical evaluation of phenoxazine and benzophenoxazine analogs.
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2.4.4 Structural assessment of the antimalarial “drug-likeness” of analogs
The design of the following phenoxazine and benzophenoxazine analogs as antiprotozoal were
based off revisited trends found in the evaluation of commercially available tricyclic cations with
amine bearing side chains. Methylene blue (MB) is a tricyclic cation previously coined the magic
bullet for its ability to specifically stain and kill plasmodium parasite and other protozoal
infections. The plasmodium parasite gains its virulence inside its human host during its blood stage
by invading red blood cells and consuming hemoglobin as its main nutrient source, leaving behind
hematin, where the heme’s iron is in its oxidized (+3) state which is responsible for the production
of reactive oxygen species leading to oxidative stress to the parasite.80 Through evolutionary
ingenuity, the malaria parasite has engineered a detoxification process crucial for its survival by
forming insoluble aggregate of the toxic heme groups called hemozoin or malaria pigment.
Although solid-state structural identification of hematin has not been achieved, there exist
conclusive evidence that hemozoin is structurally identical to synthetic β-hematin which consist
of strands of Fe (III)-porphyrin units, linked into a polymer by propionate oxygen-iron bonds.81
MB and many other tricyclic cationic molecules have been speculated to target the sequestration
of hemozoin. They have been postulated to accumulate in the digestive vacuoles of malaria
parasites and act by blocking the heme polymerization through:
1. directly binding heme monomers and preventing the polymerization of heme82
2. inhibiting enzymatic processes involved in the polymerizing heme83
3. or through the interaction and subsequent decrystallization of hemozoin in the
digestive vacuole of P. falciparum 83
Methylene blue has been used to enhance the efficacy of known therapeutic malaria
treatments through the non-competitive inhibition of Plasmodium falciparum glutathione
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reductase (GR), a redox enzyme responsible for buffering intercellular oxidative stress, by
retaining low glutathione levels inside the cytosol of malaria cells and in turn enhances the activity
of some antimalarial agents such as chloroquine, dihydroartemisinin, and mefloquine.84
Tricyclic cationic compounds with N-substituted alkyl chains have been found more active
against malaria, perhaps because of increased lipophilicity which can enhance the molecules’
cellular diffusion. Once inside the cell, the molecules can invoke its antimalarial abilities through
the multiple mode of actions plausible for its class. A review of recently publish studies conducting
the evaluation of tricyclic cations related to MB as antimalarial reveals a general trend in the
alkylation of the scaffold’s donor and acceptor nitrogen groups and their antimalarial potency. A
carbon chain length of ≤3 on their amine has been described as the “sweet spot” to attain favorable
lipophilicity while maintaining adequate antimalarial potency. Chain longer than 3 carbons have
been shown to reduce the potency of the drugs. This is perhaps due to the steric blockade imposed
by the flailing alkyl chain during the ligand to heme interaction. Another featuring that was
discovered to enhance the drug profile of the scaffold against malaria was the addition of dimethyl
group at their 2, 8 positions or a single methyl group at either position. A comparative biophysical
study of the binding of two analogous tricyclic cations with lysozyme, a protein abundant in
protective fluids of a lot of mammals, showed the superior ability of an analog containing a methyl
group at the 8 position to the protein over the corresponding analog lacking a methyl group.83 We
designed a series of compounds featuring small analogous changes that could be used to begin
defining factors affecting their antimalarial potency. Compounds 25a-e containing N-alkylated
amines of carbon length shorter than 3 with or without a methyl group at their 2 position were
selected to investigate the effect of the structural modification on the antimalarial potency of the
analog set.
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We also designed and synthesized a derivative of a known phenoxazine analog SSJ208 with
good antimalarial activity (IC50= 0.006 μM) by adding a 2-hydroxy moiety to the cyclic amine to
take investigate the postulated mechanism of action of hemozoin decrystallization by delocalized
lipophilic cations containing amine bearing side chain and groups with the ability to donate
electron proposed by Ulrich et al.85 The idea is that the ligand can interact with the aggregated
hemozoin, hypothetically by binding the heme groups to the hydrophilic surface of the molecule
through π- π stacking and aggregation due to its planar delocalized structure, while the iminium
moiety of could interact with the carboxylate of the heme through electrostatic interaction, placing
the hydroxy moiety in the crux of hematin’s iron to oxygen bridge. The Oxygen could act as a
reducer of the Fe3+ of the bridge to Fe2+, in the process breaking the Fe-O bond and releasing the
toxic hematin. Crystal structure and biophysical studies of the interaction of the molecule with
heme should be conducted to support this hypothesis, upon antimalarial evaluation.
Benzo[a]phenoxazine derivatives were also designed with investigative features in mind
geared towards enhancing antimalarial property. The phenyl ring was adapted onto the dye
architecture to enhance the hydrophobicity and planarity of the dye required for adhesion onto the
surface of the heme. We also maintained an unsubstituted iminium at the 7 position to investigate
its effect on the antimalarial potency of the analog set. The presence of both fully substituted amine
and primary imine on the scaffold means the presence of groups sensitive to changes in proton
concentration, indeed Nile blue analogs are known to be pH sensitive dyes. The designed
compounds are predicted to reversibly change from their protonated state to neutral to reversibly
enter the parasite digestive vacuole (pKa ~3.7-6.5), the site of hemoglobin degradation.86 We
previously concluded through an investigative study of the binding of alkylated Nile blue dyes
with Human serum albumin (HSA) that mono substituted analogs did not bind at all to the protein
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and that the di-substituted dyes showed a slight improvement in binding. HSA is the most common
protein found in human blood plasma, and thus the most used mechanism for transporting drugs
inside the body and delivery them to their target.87 The effective binding of a drug candidate to
HSA can have a pronounced effect on drug efficacy, retention/clearance, and toxicity. We sought
to included cyclic alkyl groups retaining the C ≤3 rule to enhance HSA binding of the compounds.
2.4.5 Biodistribution
One of the main drawbacks in the used of tricyclic cationic molecules is their ability to stain
internal tissues. Another reason for designing benzo[a]phenoxazine analogs was to increase the
lipophilicity of the molecules and encourage total clearance without organ staining. Analogs of the
benzo[a]phenoxazine containing N-alkylated and varying cyclic amine and their 2-hydroxy
bioisostreres were synthesized to increase clearance and decrease staining of organs. A selected
member of the benzo[a]phenoxazine class 20 containing a pyrrolidinyl group was selected for in
vivo biodistribution studies in a mice model through our collaborator at the Massachusetts General
Hospital and Harvard Medical School, shown in Figure 2.15 and 2.16. The imaging data shows
that the compound cleared though all internal organs and accumulated in the small intestines
through the gall bladder and biliary tract, signifying that the molecule is absorbed through the gut
when administered, and has higher clearance and no profuse staining of tissues.
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Figure 2.15 Biodistribution imaging of compound 2a

Figure 2.16 Gallbladder uptake of compound 2a
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3

Conclusion

The oxazine core represents an attractive scaffold from which fluorescent probes of the
phenoxazine and benzophenoxazine have been developed. The rational design of a focused library
of polycyclic lipophilic cations was afforded through the synthetic derivatization the phenoxazine
and benzophenoxazine with the principle aim of mimicking recent trends found in the development
of potent antimalarial to cater to the enhancement of their “drug like” profile. This work presents
14 dyes and their photophysical and physicochemical properties, a structural assessment of their
antimalarial “drug like” profile, and the biodistribution studies of analog 20. Such modification,
in conjunction with the proven effectiveness of the scaffold, could lead to the development of
effective antimalarial agents. The following libraries are currently being evaluated in vitro for their
antimalarial efficacy against drug sensitive malaria strain NF5 and the multidrug-resistant strain
K1, and for their antitrypanosomal properties against T. brucei cells. Their toxicity against
mammalian cells will be studied to determine their selectivity.
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4

Experimental

Alkylation of 3-aminophenol. 3-Aminophenol (45.82 mmol) was dissolved in DMF along with
K2CO3 (2 mol. equ.). The mixture was sonicated and allowed to mix for 15 minutes. Alkyl halide
(2 equ. in respect to 3-aminophenol) were added dropwise at room temperature. The mixture was
left to stir at room temperature for an additional 15 min and then was gradually heated to a
maximum temperature of 70 °C over the course of two hours. TLC confirmed that all the starting
material had been consumed but that three products had formed. The products were separated via
regular phase column chromatography eluting first with Hexanes. This was increased to 7:3
Hex/AcOEt to finish the separation. The middle spot was confirmed by spectroscopic analysis of
the eluting products to be the desired compound.
3-(dimethylamino)phenol. Compound 27a. Yield 43%. 1H NMR (400 MHz, (CD3)2SO-d6): δ
8.992 (s, 1H), δ 6.932 (t, J= 8 Hz, 1 H), δ 6.155 (d, J= 8.4 Hz, 1 H), δ 6.101 (s, 1 H), δ 6.079 (d,
J= 8 Hz, 1H), δ 2.824 (S, 6H); 13C NMR (100 MHz, CDCl3) δ 100.00, 104.11, 104.25, 129.92,
152.29, 158.55.
3-(diethylamino)phenol. Compound 27b. Yield 38%. 1H NMR (400 MHz, (CD3)2SO-d6): δ
8.914 (s, 1H), 6.892 (t, J= 8 Hz, 1H), 6.095 (d, J= 2.4 Hz, 1H), 6.078 (s, 1 H), 5.987 (d, J= 7.6 Hz,
1H), 3.248 (q, J= 7 Hz, 4H), 1.054 (t, J= 7 Hz, 6H).

C NMR (100 MHz, DMSO-d6) δ 25.22,

13

48.77, 19.06, 29.64, 43.94, 95.26, 120.05, 130.71, 144.29, 162.77, 166.70; m.p. 156-158 °C.
3-(pyrrolidin-1-yl)phenol and 3-(piperidin-1-yl)phenol. Compound 28a-d: A mixture of 3aminophenol (1 equ.) or m-anisidine with 1,4-dichlorobutane (1.2 equ.) or 1,5-dichloropentane
was refluxed in dry toluene for 24 h and then cooled to room temperature. Triethyl amine (2 equ.)
and sodium carbonate (1 equ.) in 10 ml distilled water were added to the mixture. The reaction
mixture was refluxed for another 24 h. After completion of the reaction, the solvent was reduced
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and the organic portion was extracted with CH2Cl2. The solvent was evaporated and the crude
product was purified using silica gel column chromatography with petroleum ether/ethyl acetate
as the eluent to yield off white crystals.
3-(pyrrolidin-1-yl)phenol. Compound 28a. 45% yield. 1H NMR (400 MHz, CDCl3) δ 8.967 (s,
1H), 6.909 (t, J= 8 Hz, 1H), 6.021 (d, J = 8Hz, 1H), 5.974 (d, J= 8Hz, 1H), 5.935 (s, 1H), 3.137
(t, 4H), 1.903 (t, 4H), 1.526 (m, 2H).

C NMR (100 MHz, DMSO-d6) δ 25.35, 47.81, 99.24,

13

103.38, 103.71, 130.01, 149.39, 158.58.
1-(3-methoxyphenyl)pyrrolidine. Compound 28b. 74% yield. 1H NMR (400 MHz, CDCl3) δ
1.917 (q, J= 3.2Hz, 4H), 3.187 (m, 4H), 3.741 (s, 3H), 6.164 (q, J= 6.4Hz, 1H), 6.236 (q, J= 5.6
Hz, 1H), 7.084 (t, J=8.4, 1H). 13C NMR (100 MHz, DMSO-d6) δ 25.42, 31.44, 34.09, 47.73, 55.00,
98.01, 100.94, 105.15, 129.93, 149.41, 160.88.
3-(piperidin-1-yl)phenol. Compound 28c. 68% yield. 1H NMR (400 MHz, CDCl3) δ 9.048 (s,
1H), 6.956 (t, J= 8.2, 1H), 6.352 (d, J = 8.4 Hz, 1H), 6.291 (s, 1H), 6.172 (d, J= 8Hz, 1H), 3.063
(t, J= 5Hz, 4H), 1.583 (t, 4H), 1.520 (m, 2H).

13

C NMR (100 MHz, DMSO-d6) δ 24.33, 25.62,

50.24, 103.42, 106.43, 107.63, 129.97, 153.21, 158.54.
1-(3-methoxyphenyl)piperidine. Compound 28d. 55% yield. 1H NMR (400 MHz, DMSO-d6) δ
7.092 (t, J= 8.4 Hz, 1H), δ 6.488 (d, J= 2 Hz, 1H), δ 6.446 (t, J= 2.4 Hz, 1H), δ 6.346 (d, J= 7.5
Hz, 1H), δ 3.711(s, 3H), δ 3.097 (t, J= 5.2 Hz, 4H), δ 1.596 (m, 4H), δ 1.521 (t, J= 5.6 Hz, 1H).
C NMR (100 MHz, DMSO-d6) δ 25.47, 25.76, 50.04, 55.14, 102.32, 104.04, 108.97, 129.89,

13

153.50, 160.69.
1-(3-hydroxyphenyl)pyrrolidin-3-ol. Compound 29. 38% yield. 1H NMR (400 MHz, CDCl3) δ
1.854 (m, 1H), δ 2.035 (m, 1H), 3.027 (t, 1H), 3.025-3.371 (m, 3H), 4.377 (s, 1H), 4.938 (s, J= 8
Hz, 1H), 5.923 (s, 1H), 5.964 (d, J= 8.4 Hz, 1H), 6.024 (d, J= 1.2 Hz, 2H), 6.925 (t, J= 1.2 Hz,
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2H), 8.981 (s, 1H), 13C NMR (100 MHz, DMSO-d6) δ 34.17, 45.85, 56.41, 69.76, 98.89, 103.18,
103040, 130.04, 149.49, 158.60.
3-(piperazin-1-yl)phenol hydrochloride. Compound 30. 35% yield. A round bottom flask
charged with 3-aminophenol (1 equ.) and bis(2-chloroethyl)amine hydrochloride (1.3 equ.) and 20
mL of sulfolane was heated to 150 °C overnight, by which the time the reaction was completed as
monitored by TLC. The reaction mixture was cooled to 45 °C and diluted with 50 mL of acetone
and further cooled to 0°C. The mixture was maintained at 0°C for 1 more hour to precipitate the
desired product, which was filtered and washed with chilled acetone and dried under vacuum to
yield the pure product as light brown crystals. 1H NMR (400 MHz, CDCl3) δ 9.551 (s, 1H), 7.066
(t, J= 8.2, 6H), 6.500 (d, J = 10.8Hz, 1H), 6.483 (S, 1H), 6.38 (d, J= 8, 1H), 3.382 (t, 4H), 3.22 (t,
4H). 13C NMR (100 MHz, DMSO-d6) δ
General procedure for the nitrosylation of alkylated 3-aminophenols. A solution of Nalkylated aminophenol dissolved in 1:1 ethanol/HCl was stirred in an ice bath. Over a period of 1
h, NaNO2 (1 mol. eq.) in 2 mL of water was slowly added to the mixture dropwise. The solution
was left to stir on an ice bath for the remainder of the reaction to maintain a temperature at 0-5 °C.
Precipitate was collect by vacuum filtration, and then used without any further purification to avoid
decomposition. In the cases where no precipitate formed, the reaction pH was adjusted to ~9 with
K2CO3, and extracted with ethyl acetate. The combined organic layers were dried from magnesium
sulfate and concentrated under reduced pressure to give the nitroso compound.
General Procedure for Synthesis of flexible, and cyclic phenoxazinium dyes. Nitroso
compounds were dissolved in in i-PrOH (10 ml) in the presence of a catalytic amount of HClO4.
A solution of compound the respective napthalamine in i-PrOH (10 ml) was added dropwise to the
above mixture in 30-45 min and heated at 75 °C. The reaction was monitored via UV-Vis. After
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completion, the dark blue solution was concentrated under reduced pressure. The residue was ultrasonicated in ethanol/ether for 30 min and filtered to yield the dye. Some dyes were purified by
column chromatography with silica gel, eluting with various concentration of Hex/AcOEt
9-(dimethylamino)-2-hydroxy-5H-benzo[a]phenoxazin-5-iminium perchlorate. Compound
19a. 27 % yield. 1H NMR (400 MHz, CDCl3) δ 11.065 (s, 1H), 9.944 (s, 1H), 9.819 (s, 1H), 8.348
(d, J= 8.8 Hz, 1H), 8.064 (s, 1H), 7.726 (d, J= 9.2 Hz, 1H), z`7.261 (d, J= 3.7, 1H), 7.088 (d, J=8
Hz, 1H), 6.844 (s, 1H), 6.714 (s, 1H), 3.201 (s, 6H). 282-284 °C
9-(diethylamino)-2-hydroxy-5H-benzo[a]phenoxazin-5-iminium

perchlorate.

Compound

19b. 18 % yield. 1H NMR (400 MHz, CDCl3) δ 11.184 (s, 1H), 10.310 (s, 1H), 10.027 (s, 1H),
8.409 (d, J= 8.8 Hz, 1H), 7.990 (s, 1H), 7.613 (d, J= 9.2 Hz, 1H), 7.222 (d, J= 8, 1H), 7.006 (d,
J=9.2 Hz, 1H), 6.829 (s, 1H), 6.778 (s, 1H), 1.281-1.024 (m, 10H). 285-287 °C
9-(pyrrolidin-1-yl)-5H-benzo[a]phenoxazin-5-iminium perchlorate. Compound 20. 13%
yield. 1H NMR (400 MHz, CDCl3) δ 2.041 (m, 4H), 3.494 (m, 4H), 6.673 (s, 1H), 6.755 (s, 1H),
6.973 (d, J= 7.2, 1H), 7.711(d, J= 8.8 Hz, 1H), 7.851 (t, J= 7.6, 1H), 7.959 (t, J=7.2 Hz, 1H), 8.401
(d, J=8, 1H), 8.702 (d, J=7.6, 1H), 9.741(d, 2H). (100 MHz, DMSO-d6) δ 29.16, 48.54, 55.78,
58.25, 69.19, 70.24, 77.03, 96.75, 97.21, 117.80, 119.13, 133.84, 134.00, 134.69, 149.85, 155.37,
157.51, 166.85. 260-264 °C
9-(piperidin-1-yl)-5H-benzo[a]phenoxazin-5-iminium perchlorate. Compound 21. 11% yield.
1

H NMR (400 MHz, CDCl3) δ 2.041 (m, 4H), 3.494 (m, 4H), 6.673 (s, 1H), 6.755 (s, 1H), 6.973

(d, J= 7.2, 1H), 7.711(d, J= 8.8 Hz, 1H), 7.851 (t, J= 7.6, 1H), 7.959 (t, J=7.2 Hz, 1H), 8.401 (d,
J=8, 1H), 8.702 (d, J=7.6, 1H), 9.741(d, 2H). (100 MHz, DMSO-d6) δ 29.16, 48.54, 55.78, 58.25,
69.19, 70.24, 77.03, 96.75, 97.21, 117.80, 119.13, 133.84, 134.00, 134.69, 149.85, 155.37, 157.51,
166.85. 260-264 °C
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9-(piperazin-1-yl)-5H-benzo[a]phenoxazin-5-iminium perchlorate. Compound 22. 13% yield.
1

H NMR (400 MHz, CDCl3) δ 10.533 (s, 1H), 10.403 (s, 1H), 9.173 (s, 1H), 7.974 (t, J= 7.6, 1H),

7.405 (d, J= 2 Hz, 1H), 7.382 (d, J= 2 Hz, 1H), 7.291 (s, 1H), 6.949 (s, 1H), 7.828 (t, J=7.6 Hz,
1H), 7.511 (s, 1H), 3.880 (t, 4H), 3.287 (t, 4H). 291-293 °C
2-hydroxy-9-(piperazin-1-yl)-5H-benzo[a]phenoxazin-5-iminium perchlorate. Compound
22b. 11 % yield. 1H NMR (400 MHz, CDCl3) δ 11.230 (s, 1H), 10.374 (s, 1H), 10.250 (s, 1H),
9.245 (s, 1H), 8.417 (d, J=8.8 Hz, 1H), 8.135 (s, 1H), 7.873 (d, J= 9.2 Hz, 1H), 7.342-7.320(m,
2H), 7.262 (s, 1H), 6.808 (s, 1H), 3.846 (t, 4H), 3.262 (t, 4H). (100 MHz, DMSO-d6) δ 42.75,
44.30, 97.38, 99.27, 109.87, 114.77, 115.76, 119.95, 127.96, 128.15, 132.16, 134.68, 138.52,
147.21, 152.19, 154.14, 162.84, 162.90.
(E)-1-(7-(dimethylamino)-3H-phenoxazin-3-ylidene)-3-hydroxypyrrolidin-1-ium

chloride.

Compound 25f. 7 % yield. 1H NMR (400 MHz, CDCl3) δ 11.230 (s, 1H), 10.374 (s, 1H), 10.250
(s, 1H), 9.245 (s, 1H), 8.417 (d, J=8.8 Hz, 1H), 8.135 (s, 1H), 7.873 (d, J= 9.2 Hz, 1H), 7.3427.320(m, 2H), 7.262 (s, 1H), 6.808 (s, 1H), 3.846 (t, 4H), 3.262 (t, 4H).

General Procedure for the preparation of 4-arylazo-1-naphthylamines. A solution of the
appropriate p-nitrophenyldiazonium (1 equ.) in aqueous sulfuric acid was added to a solution (100
mL) of the appropriate 1-naphthylamine or amino quinoline under stirring. After 1h, the cooled
reaction mixture was neutralized with aqueous NaOH, and the precipitated product filtered off and
recrystallized from n-butanol to yield pure 4-Arylazo-1-naphthylamines.
(E)-4-((4-nitrophenyl)diazenyl)naphthalen-1-amine. Compound 35. 78 % yield. 1H NMR (400
MHz, CDCl3) δ 8.924 (d, J= 8.4 Hz, 1H), 8.376 (d, J= 2 Hz, 2H), 8.254 (d, 1H), 8.061 (m, 3H),
7.693 (t, J= 7.4 Hz, 1H), 7.548 (m, 3H), 6.820 (d, J= 8.8 Hz, 1H). (100 MHz, DMSO-d6) δ 108.74,
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117.55, 121.37, 122.80, 123.10, 123.22, 123.31, 125.25, 125.31, 125.51, 128.88, 134.48, 137.67,
146.62, 153.37, 157.54.
General Procedures for the preparation of bridged phenoxazinium Dyes. A mixture respective
aminophenol and the appropriate 4-arylazo-1-naphthylamine dissolved in IPA (50 mL) containing
perchloric acid was refluxed at 85 °C. Reaction progression was monitored using TLC, and UVVis spectroscopy until completion. After cooling to room temperature the reaction mixture was
concentrated under reduced pressure, the product was ultra-sonicated in 5ml of ethanol, filtered
off to give the pure dye. In some cases, it was found necessary to purify the product by column
chromatography on silica gel, using various concentrations of Hex/AcOEt as the eluent.
9,10,11,12-tetrahydro-5H-benzo[a]pyrido[2,3-i]phenoxazin-5-iminium

perchlorate.

Compound 23. 56 % yield. 1H NMR (400 MHz, CDCl3) δ 9.453 (s, 2H), 9.089 (s, 1H), 8.797 (d,
J = 8 Hz, 1H), 8.453 (d, J= 8, 1H), 7.974 (t, J= 7.6, 1H), 7.853 (t, J=7.6 Hz, 1H), 7.660 (s, 1H),
6.840 (s, 1H), 6.711 (s, 1H), 3.493 (t, 2H), 2.912 (m, 2H), 1.906 (m, 2H). (100 MHz, DMSO-d6)
159.89, 154.74, 154.72, 151.00, 147.71, 132.47, 313.92, 131.52, 131.23, 129.48, 126.36, 124.38,
124.11, 122.76, 96.87, 96.39, 41. 64, 26.62, 20.18. 325°C decomposed
2,3,6,7-tetrahydro-1H,5H,14H-benzo[a]quinolizino[1,9-hi]phenoxazin-14-iminium
perchlorate. Compound 24. 50 % yield. 1H NMR (400 MHz, CDCl3) δ 9.259
(s, 2H), 8.760 (d, J= 8Hz, 1H), 8.427 (d, J = 8 Hz, 1H), 7.974 (t, J= 7.6, 1H), 7.828 (t, J=7.6 Hz,
1H), 7.511 (s, 1H), 6.826 (s, 1H), 3.591 (t, 4H), 2.892 (m, 4H), 1.982 (m, 4H). (100 MHz, DMSOd6) 159.07, 151.01, 150.71, 143.45, 132.14, 131.79, 331.48, 130.71, 129.14, 128.98, 126.36,
127.16, 124.25, 124.03, 122.59, 105.47, 51.26, 50.75, 27.21, 20.48, 19.43, 19.29. 278-281°C
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